To The Moon

$Lucira Health, Inc.(LHDX)$ 

Lucira Health went public in February 2021, raising $153 million in an IPO.

The firm is developing various infectious disease testing kits.

Its first kit, for COVID-19, has produced rapidly growing revenue since launch.

LHDX is still seeking to diversify its revenue streams, so until we gain further visibility into that progress, I'm on Hold for the stock.

LHDX Signals & Forecast

There are few to no technical positive signals at the moment. The Lucira Health, Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.129 and $0.334. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, November 22, 2022, and so far it has fallen -76.85%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Lucira Health, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

$0.111 $0.120

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0210 between high and low, or 19.44%. For the last week the stock has had daily average volatility of 26.26%.

Lucira Health, Inc. is oversold on RSI14 (8). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LHDX) For The Upcoming Trading Day Of Tuesday 3rd

For the upcoming trading day on Tuesday, 3rd we expect Lucira Health, Inc. to open at $0.116, and during the day (based on 14 day Average True Range), to move between $0.0622 and $0.160, which gives a possible trading interval of +/-$0.0489 (+/-44.04%) up or down from last closing price. If Lucira Health, Inc. takes out the full calculated possible swing range there will be an estimated 88.07% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.0089 (8.01%) our system find the risk reward not very attractive.